Total Holdings
26
Portfolio diversification across 26 positions
PPH
(NASDAQ)VanEck Pharmaceutical ETF
$104.16-- (--)
Loading... - Market loading
PPH ETF Holdings: VanEck Pharmaceutical ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$1.29B
Total fund assets
Expense Ratio
0.36%
Annual management fee
Fund Issuer
VanEck
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 28 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 19.17% |
| 2 | N NVSN.MX | Novartis AG ADR | Stock | 10.84% |
| 3 |  | Novartis AG | Stock | 10.76% |
| 4 |  | Merck & Co., Inc. | Stock | 9.65% |
| 5 |  | Novo Nordisk A/S | Stock | 5.89% |
| 6 |  | Pfizer Inc. | Stock | 5.25% |
| 7 |  | GlaxoSmithKline plc | Stock | 4.96% |
| 8 | B BMY | Bristol-Myers Squibb Company | Stock | 4.83% |
| 9 |  | McKesson Corporation | Stock | 4.81% |
| 10 |  | Johnson & Johnson | Stock | 4.70% |
| 11 |  | Sanofi | Stock | 4.63% |
| 12 | L LON:AZN | AstraZeneca PLC | Stock | 4.42% |
| 13 | L LSE:AZN | AstraZeneca PLC | Stock | 4.18% |
| 14 |  | AbbVie Inc | Stock | 4.03% |
| 15 |  | Cencora, Inc. | Stock | 4.01% |
| 16 |  | Zoetis Inc. | Stock | 3.41% |
| 17 |  | Haleon plc | Stock | 3.17% |
| 18 |  | Takeda Pharmaceutical Company Limited | Stock | 3.15% |
| 19 |  | Teva Pharmaceutical Industries Limited | Stock | 2.81% |
| 20 |  | Viatris Inc. | Stock | 0.90% |
| 21 |  | Jazz Pharmaceuticals plc | Stock | 0.79% |
| 22 |  | Axsome Therapeutics, Inc. | Stock | 0.52% |
| 23 |  | Elanco Animal Health Incorporated | Stock | 0.44% |
| 24 |  | Corcept Therapeutics Incorporated | Stock | 0.23% |
| 25 |  | Organon & Co. | Stock | 0.11% |
| 26 | T TSX:BHC | Bausch Health Companies Inc. | Stock | 0.11% |
| 27 | T TO:BHC | Bausch Health Companies Inc | Stock | 0.09% |
| 28 |  | Perrigo Company plc | Stock | 0.08% |
Frequently Asked Questions About VanEck Pharmaceutical ETF Holdings
What are the top holdings in PPH?
VanEck Pharmaceutical ETF (PPH) holds 26 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is PPH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review PPH's holdings table to analyze concentration risk.
What is PPH's sector allocation?
The Sector Allocation chart shows how PPH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PPH invest in?
PPH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PPH ETF?
PPH's diversification can be assessed by reviewing its 26 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.